Crossmark

Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer

Crossref DOI link: https://doi.org/10.1186/s13058-019-1137-9

Published Online: 2019-04-29

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Weber-Lassalle, Nana

Borde, Julika

Weber-Lassalle, Konstantin

Horváth, Judit

Niederacher, Dieter

Arnold, Norbert

Kaulfuß, Silke

Ernst, Corinna

Paul, Victoria G.

Honisch, Ellen

Klaschik, Kristina

Volk, Alexander E.

Kubisch, Christian

Rapp, Steffen

Lichey, Nadine

Altmüller, Janine

Lepkes, Louisa

Pohl-Rescigno, Esther

Thiele, Holger

Nürnberg, Peter

Larsen, Mirjam

Richters, Lisa

Rhiem, Kerstin

Wappenschmidt, Barbara

Engel, Christoph

Meindl, Alfons

Schmutzler, Rita K.

Hahnen, Eric http://orcid.org/0000-0002-1152-8367
Hauke, Jan
Funding

Funding for this research was provided by:

Deutsche Krebshilfe (110837, 70111850)

Ministry for Innovation, Science and Research of the State of North Rhine-Westphalia (323-8.0302.16.02-132142)
License Information

Text and Data Mining valid from 2019-04-29
More Information

Article History

Received: 18 January 2019

Accepted: 12 April 2019

First Online: 29 April 2019

Ethics approval and consent to participate

: Written informed consent was obtained from all patients and control individuals, and ethical approval was granted by the Ethics Committee of the University of Cologne (07-048).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.